Stockchase Opinions

David Burrows Herbalife Ltd. HLF-N DON'T BUY Apr 21, 2015

You take on some binary risks here that you don’t need to take. He would not be participating in this.

$46.760

Stock price when the opinion was issued

0
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY

When you get such big boys playing in this game she lets them have their turf. Too much controversy.

DON'T BUY

This is one of the great business stories of the year, and no one knows how it is going to end. Is this a giant scam, a pyramid scheme, is it going to get shut down by the marketing by the Federal Trade Commission? If you believe the numbers, it is not a bad company. It has had good growth and seems to be trading at a reasonable price. If you think that all the sales are non-repeatable and are only selling to the people who are supposed to be selling to end users and no product is getting up to the marketplace, then it is bound to collapse. He wouldn’t touch this one.

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly HLF is a nutritional supplement and weight management product company. Management revised upward its 2021 guidance in light of pandemic related demand growth. At 13x earnings, it trades at a good discount to its peers and earnings growth has been 11% annually over the past 5 years allowing its cash flow position to grow. We would buy this with a stop-loss at $35, looking to achieve $70 -- upside potential over 50%. Yield 0% (Analysts’ price target is $69.67)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly HLF is a nutritional food company, who is seeing sales benefit from the need to improve diets as the pandemic winds down. Recently reported quarterly sales were up 19% and EPS improved by 71% from year ago levels. Both beat analyst expectations and management again upgraded its guidance. Marketing is focusing on how 28 NFL draft picks have been training with their products. It trades at 19x earnings, compared to peers over 34x. We would buy this with a stop loss at $39, looking to achieve $69 -- upside potential over 39%. Yield 0% (Analysts’ price target is $69.67)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick May 13/21, Down 21.2%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with HLF has triggered its stop at $39. To remain disciplined, we recommend covering the position at this time. We will look for better opportunities.
DON'T BUY

Has no growth and is too controversial.